Milestone Pharmaceuticals Inc

NASDAQ:MIST   3:59:54 PM EDT
5.40
-0.08 (-1.51%)
Earnings Announcements

Milestone Pharmaceuticals Reports First Quarter 2022 Financial Results And Provides Clinical And Corporate Update

Published: 05/12/2022 11:22 GMT
Milestone Pharmaceuticals Inc (MIST) - Milestone Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Corporate Update.
Milestone Pharmaceuticals Inc - Rapid Topline Data Readout Remains on Track for Mid-second Half 2022.
Milestone Pharmaceuticals Inc Qtrly Loss per Share $0.33.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.